Strategies for Measuring the Quality of Psychotherapy: A White Paper to Inform Measure Development and Implementation : Table 5

05/15/2014

: Table 5

Guideline DeveloperTerm and Definition
American Psychiatric AssociationSubstantial clinical confidence: Definition not provided in guideline. Moderate clinical confidence: Definition not provided in guideline. Guideline Workgroup and Guideline Steering Committee: The guideline was developed by a work group and under the direction of a steering committee.
National Institute for Health and Clinical Excellence (for depression and anxiety)Very low: Any estimate of effect is uncertain. Low: Further research is very likely to have an important impact on our confidence in the estimate of the effect and is likely to change the estimate. Moderate: Further research is likely to have an important impact on our confidence in the estimate of the effect and may change the estimate. High: Further research is very unlikely to change our confidence in the estimate of the effect.
National Institute for Health and Clinical Excellence (for PTSD)Treatment shows clinically important benefits: At least one RCT as part of a body of literature of overall good quality and consistency addressing the specific recommendation without extrapolation. Good practice point: Based on the clinical experience of the guideline development group.
U.S. Department of Veteran Affairs/ U.S. Department of DefenseStrong recommendation to provide the treatment: Good evidence was found that the intervention improves important health outcomes and concludes that benefits substantially outweigh harm. No recommendation for or against the routine provision of the treatment: At least fair evidence was found that the intervention can improve health outcomes, but concludes that the balance of benefits and harms is too close to justify a general recommendation.
Australian Center for Post Traumatic Mental HealthBody of evidence can be trusted to guide practice: Grade A rating; no further definition provided.